Eaton Vance Management Has $83.33 Million Position in Stryker Corporation (SYK)
Eaton Vance Management trimmed its stake in shares of Stryker Corporation (NYSE:SYK) by 0.0% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 600,464 shares of the medical technology company’s stock after selling 39 shares during the quarter. Eaton Vance Management owned 0.16% of Stryker Corporation worth $83,332,000 as of its most recent SEC filing.
Several other large investors also recently added to or reduced their stakes in the stock. Vanguard Group Inc. boosted its stake in Stryker Corporation by 5.2% in the 1st quarter. Vanguard Group Inc. now owns 23,421,053 shares of the medical technology company’s stock worth $3,083,382,000 after purchasing an additional 1,161,688 shares during the period. BlackRock Inc. grew its holdings in Stryker Corporation by 2,526.4% during the 1st quarter. BlackRock Inc. now owns 21,976,771 shares of the medical technology company’s stock valued at $2,893,242,000 after buying an additional 21,140,000 shares in the last quarter. Fundsmith LLP grew its holdings in Stryker Corporation by 4.6% during the 1st quarter. Fundsmith LLP now owns 5,175,453 shares of the medical technology company’s stock valued at $681,348,000 after buying an additional 226,057 shares in the last quarter. Wellington Management Group LLP grew its holdings in Stryker Corporation by 0.5% during the 1st quarter. Wellington Management Group LLP now owns 4,569,118 shares of the medical technology company’s stock valued at $601,525,000 after buying an additional 24,139 shares in the last quarter. Finally, Geode Capital Management LLC grew its holdings in Stryker Corporation by 6.3% during the 1st quarter. Geode Capital Management LLC now owns 2,786,406 shares of the medical technology company’s stock valued at $366,255,000 after buying an additional 166,133 shares in the last quarter. Institutional investors own 74.13% of the company’s stock.
In related news, insider David Floyd sold 19,305 shares of the company’s stock in a transaction on Wednesday, July 12th. The shares were sold at an average price of $144.56, for a total transaction of $2,790,730.80. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Graham A. Mclean sold 1,124 shares of the company’s stock in a transaction on Tuesday, August 8th. The shares were sold at an average price of $146.26, for a total transaction of $164,396.24. Following the sale, the insider now directly owns 8,983 shares in the company, valued at approximately $1,313,853.58. The disclosure for this sale can be found here. In the last ninety days, insiders sold 25,429 shares of company stock worth $3,686,927. Corporate insiders own 7.40% of the company’s stock.
Several equities research analysts have recently weighed in on SYK shares. SunTrust Banks, Inc. reiterated a “buy” rating and set a $161.00 price target on shares of Stryker Corporation in a research report on Monday. BidaskClub upgraded shares of Stryker Corporation from a “hold” rating to a “buy” rating in a research report on Thursday, August 17th. Cowen and Company restated a “buy” rating and issued a $160.00 price objective (up from $150.00) on shares of Stryker Corporation in a research report on Sunday, July 30th. Zacks Investment Research cut shares of Stryker Corporation from a “buy” rating to a “hold” rating in a research note on Wednesday, August 23rd. Finally, Oppenheimer Holdings, Inc. set a $148.00 price objective on shares of Stryker Corporation and gave the company a “hold” rating in a research note on Friday, July 28th. Two investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and twelve have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $146.78.
Shares of Stryker Corporation (NYSE:SYK) opened at 142.02 on Monday. The company has a market capitalization of $53.12 billion, a price-to-earnings ratio of 31.70 and a beta of 0.81. The stock has a 50 day moving average of $143.56 and a 200-day moving average of $138.98. Stryker Corporation has a one year low of $106.48 and a one year high of $148.84.
Stryker Corporation (NYSE:SYK) last announced its quarterly earnings results on Thursday, July 27th. The medical technology company reported $1.53 EPS for the quarter, beating analysts’ consensus estimates of $1.51 by $0.02. Stryker Corporation had a return on equity of 24.26% and a net margin of 14.22%. The company had revenue of $3.01 billion during the quarter, compared to analyst estimates of $2.98 billion. During the same period in the prior year, the company earned $1.39 earnings per share. The firm’s revenue was up 6.1% on a year-over-year basis. On average, equities analysts expect that Stryker Corporation will post $6.46 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 31st. Shareholders of record on Friday, September 29th will be paid a $0.425 dividend. This represents a $1.70 dividend on an annualized basis and a yield of 1.20%. The ex-dividend date is Thursday, September 28th. Stryker Corporation’s payout ratio is 37.95%.
WARNING: This news story was first reported by Watch List News and is the property of of Watch List News. If you are reading this news story on another site, it was illegally copied and reposted in violation of US and international trademark & copyright laws. The correct version of this news story can be viewed at https://www.watchlistnews.com/eaton-vance-management-has-83-33-million-position-in-stryker-corporation-syk/1602343.html.
Stryker Corporation Company Profile
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).
Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.